CFDA Aims To Fully Implement New GSP Standards By 2016
This article was originally published in PharmAsia News
China FDA recently requested full new good storage practices (GSP) implementation before 2016, while giving companies that handle pharmaceuticals a grace period to the end of June next year to get assessments in order.
You may also be interested in...
NeuClone has reported that its NeuCeptin proposed biosimilar trastuzumab has successfully met all primary and secondary endpoints in a Phase I clinical trial.
Products from Novartis, Celgene and Merck could get an EU approval recommendation at this week's CHMP meeting.